Prescription and Reimbursement: Navigating Uncharted Waters in Digital Therapeutics.
Path to prescribe or reimburse DTx is currently unclear: how are physicians prescribing DTx to their patients, and how are patients paying for them?
Current integration of DTx is focused on a combination of DTx with pharmaceutical products - does this increase the likelihood to be reimbursed, and/or create an easier path to federal approval?
Is Employer’s Insurance an easy in for DTx companies?
Check out the webinar now!